Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Trading Down 0.3% – Here’s What Happened

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)’s stock price fell 0.3% during trading on Tuesday . The company traded as low as $36.23 and last traded at $36.37. 1,005 shares changed hands during mid-day trading, a decline of 46% from the average session volume of 1,861 shares. The stock had previously closed at $36.49.

Innovator IBD Breakout Opportunities ETF Stock Performance

The company has a market cap of $10.91 million, a PE ratio of 28.69 and a beta of 1.08. The business’s 50-day moving average is $37.45 and its 200 day moving average is $37.35.

Hedge Funds Weigh In On Innovator IBD Breakout Opportunities ETF

Institutional investors and hedge funds have recently bought and sold shares of the stock. Susquehanna International Group LLP boosted its stake in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after purchasing an additional 7,817 shares during the period. Nova Wealth Management Inc. increased its stake in shares of Innovator IBD Breakout Opportunities ETF by 109.4% in the first quarter. Nova Wealth Management Inc. now owns 23,978 shares of the company’s stock worth $870,000 after buying an additional 12,528 shares during the period. Comprehensive Wealth Management LLC raised its holdings in Innovator IBD Breakout Opportunities ETF by 60.5% during the 3rd quarter. Comprehensive Wealth Management LLC now owns 10,544 shares of the company’s stock valued at $411,000 after buying an additional 3,976 shares during the last quarter. Finally, Osaic Holdings Inc. boosted its position in Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after buying an additional 597 shares during the period.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.